FDA Calendar

Nov. 12-17, San Diego

69th ANNUAL SCIENTIFIC MEETING OF THE AMERICAN COLLEGE OF RHEUMATOLOGY

Presentations on latest products and services available to rheumatologists and other physicians and researchers, includes presentation from Genentech Inc. on Rituxan for rheumatoid arthritis

Nov. 14-18, Philadelphia

AACR-NCI-EORTC INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS: DISCOVERY, BIOLOGY AND CLINICAL APPLICATIONS

Includes sessions on cancer drug discovery and development as well as presentation from Sunesis Pharmaceuticals Inc. on SNS-595 for cancer and kinase inhibitor programs, presentation from NeoPharm Inc. on preliminary phase 1 results of NeoLipid formulation, presentation from Array BioPharma Inc. on MEK inhibitor ARRY-142886 for advanced solid malignancies, presentation from Cytokinetics Inc. on ispinesib trials, report from Seattle Genetics Inc. on antibody-drug conjugate technology and presentation from Sonus Pharmaceuticals Inc. on preclinical results with camptothecin derivative SN2310

Nov. 16-17, Gaithersburg, Md.

PEDIATRIC ADVISORY COMMITTEE (FDA)

Discussion on recommendation from Pediatrics Ethics Subcommittee meeting on Institution Review Board referral and clinical trial designs and devices to treat pediatric obesity

Nov. 16-17, Bethesda, Md.

VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE (FDA)

Includes presentation on use of Madin-Darby canine kidney cells for manufacture of inactivated influenza vaccines and pneumococcal vaccines

Nov. 17-18

PEPTIDES AND THERAPEUTIC PROTEINS: NEW OPPORTUNITIES FOR MACROMOLECULE DEVELOPMENT, DELIVERY AND COMMERCIALIZATION

Presentations on how proteins and peptides are becoming therapeutically viable as new technologies, delivery systems and R&D advances are converging to commercialize macromolecules

Nov. 18, Rockville, Md.

ADVISORY COMMITTEE ON SPECIAL STUDIES RELATING TO THE POSSIBLE LONG-TERM HEALTH EFFECTS OF PHENOXY HERBICIDES AND CONTAMINANTS FOR RANCH HAND ADVISORY COMMITTEE (FDA)

Discussion on updates and interactions with the Institute of Medicine's Air Force Health Study disposition study committee

Nov. 18, Gaithersburg, Md.

PEDIATRIC ADVISORY COMMITTEE (FDA)

Discussion on report by the agency on adverse event reporting for Agrylin, Paraplatin, Diflucan, camptosar, Tamiflu, Vioxx, Ferrlecit and Imitrex

Dec. 2, Gaithersburg, Md.

PSYCHOPHARMACOLOGIC DRUGS ADVISORY COMMITTEE (FDA)

Discussion on new drug application for Noven Pharmaceuticals' Methypatch for attention deficit hyperactivity disorder

Dec. 8-11, San Antonio

28th ANNUAL SAN ANTONIO BREAST CANCER SYMPOSIUM

Geared toward academic and private physicians and researchers involved in breast cancer in medical, surgical and radiation oncology as well as other health care professionals

Dec. 10-13, Atlanta

47th ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY

Includes comparison of minority recruitment of cord blood versus bone marrow donors and presentation from AnorMED Inc. on stem cell mobilizer Mozobil and Allos Therapeutics Inc. on antifolate PDX

Dec. 16-19, Washington, D.C.

INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Includes lectures from infectious disease experts, presentations on vaccines and antibiotics

Jan. 19-20, West Conshohocken, Pa.

CENTER FOR BUSINESS INTELLIGENCE CONFERENCE ON SCIENTIFIC STRATEGIES FOR INCREASING EFFICACY, SAFETY AND CONVENIENCE FOR THE NEXT GENERATION OF THERAPEUTICS

Focused on protein therapeutics on the market; includes presentation from Aegis Therapeutics on improvement of protein drugs and technology

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.